Loading clinical trials...
Loading clinical trials...
ChemoRadiOtherapy With Surgery Followed by Consolidation Durvalumab for Initially Unresectable Stage III NSCLC (CROWD): a Phase IV Feasibility Trial
Conditions
Interventions
Consolidation durvalumab
Locations
1
Netherlands
Amsterdam UMC, location VU Medical center
Amsterdam, Netherlands
Start Date
December 17, 2024
Primary Completion Date
December 17, 2026
Completion Date
December 17, 2028
Last Updated
April 3, 2025
NCT04585477
NCT07250477
NCT06943820
NCT05713006
NCT05557552
NCT05732974
Lead Sponsor
Idris Bahce
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions